Pyxis Oncology Elects Three Directors at Annual Meeting: Strategic Governance and Growth Outlook
Date: June 19, 2025 Executive Summary On June 2025, Pyxis Oncology, Inc. (NASDAQ: PYSX), a clinical-stage oncology company focused on developing novel therapeutics for cancer treatment, successfully held its annual shareholder meeting. During this meeting, shareholders elected three directors to the Board, reinforcing the company’s governance structure as it